|
🐜
|
Gene expression profiling predicts clinical outcome of breast cancer
16 auth.
L. J. Veer,
H. Dai,
M. V. Vijver,
Yudong He,
A. Hart,
M. Mao,
H. Peterse,
K. V. D. Kooy,
M. Marton,
A. Witteveen,
...
G. Schreiber,
R. Kerkhoven,
C. Roberts,
P. Linsley,
R. Bernards,
S. Friend
|
13 |
2002 |
13
🐜
|
|
🐜
|
A gene-expression signature as a predictor of survival in breast cancer.
21 auth.
M. J. van de Vijver,
Yudong He,
L. J. van ’t Veer,
H. Dai,
A. Hart,
D. Voskuil,
G. Schreiber,
J. Peterse,
C. Roberts,
M. Marton,
...
M. Parrish,
D. Atsma,
A. Witteveen,
A. Glas,
L. Delahaye,
Tony van der Velde,
H. Bartelink,
S. Rodenhuis,
E. Rutgers,
S. Friend,
René Bernards
|
12 |
2002 |
12
🐜
|
|
🦁
|
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients.
12 auth.
H. Dai,
L. V. van’t Veer,
J. Lamb,
Yudong He,
M. Mao,
B. Fine,
...
R. Bernards,
M. J. van de Vijver,
P. Deutsch,
A. Sachs,
R. Stoughton,
S. Friend
|
8 |
2005 |
8
🦁
|
|
🐜
|
Expression profiling predicts outcome in breast cancer
7 auth.
L. J. van ’t Veer,
H. Dai,
M. J. van de Vijver,
Yudong He,
A. Hart,
R. Bernards,
...
S. Friend
|
7 |
2002 |
7
🐜
|
|
🐜
|
No common denominator for breast cancer lymph node metastasis
10 auth.
B. Weigelt,
L. Wessels,
L. Wessels,
A. Bosma,
A. Glas,
D. S. A. Nuyten,
...
Y. He,
H. Dai,
J. Peterse,
L. J. Veer
|
6 |
2005 |
6
🐜
|
|
🐜
|
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
42 auth.
M. Mason,
C. Schinke,
Christine L. P. Eng,
F. Towfic,
Fred Gruber,
A. Dervan,
B. S. White,
Aditya Pratapa,
Y. Guan,
Hongjie Chen,
Yi Cui,
Bailiang Li,
Thomas Yu,
E. C. Neto,
K. Mavrommatis,
...
M. Ortiz,
V. Lyzogubov,
K. Bisht,
H. Dai,
F. Schmitz,
E. Flynt,
Daniel K. Rozelle,
Samuel A. Danziger,
A. Ratushny,
Sandeep Kumar Dhanda,
W. Dalton,
H. Goldschmidt,
H. Avet-Loiseau,
M. Samur,
B. Hayete,
P. Sonneveld,
K. Shain,
N. Munshi,
D. Auclair,
D. Hose,
G. Morgan,
M. Trotter,
D. Bassett,
Jonathan Goke,
B. Walker,
A. Thakurta,
J. Guinney
|
5 |
2019 |
5
🐜
|
|
🐜
|
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
34 auth.
L. Butterfield,
M. Disis,
B. Fox,
D. Kaufman,
S. Khleif,
E. Wang,
Helen X. Chen,
W. Merritt,
S. Gnjatic,
K. Davis,
I. Wistuba,
James Lindsay,
S. Adam,
F. Ramsdell,
Kellie N. Smith,
...
D. Bedognetti,
Chen Zhao,
E. Newell,
Michael Angelo,
David Furman,
M. Luksza,
P. Gherardini,
P. Hegde,
M. Cheever,
S. Fling,
S. Sweeney,
H. Dai,
Catharine Young,
J. Kirkwood,
Y. Najjar,
R. Sweis,
T. Lavallee,
H. Maecker,
Zoe Quandt
|
4 |
2018 |
4
🐜
|
|
🐜
|
Development of a microarray platform for FFPET profiling: application to the classification of human tumors
13 auth.
S. Duenwald,
Mingjie Zhou,
Yanqun Wang,
S. Lejnine,
Amit V. Kulkarni,
Jaime Graves,
Ryan Smith,
J. Castle,
G. Tokiwa,
B. Fine,
...
H. Dai,
T. Fare,
M. Marton
|
4 |
2009 |
4
🐜
|
|
🐜
|
Expression profiling predicts poor outcome of disease in young breast cancer patients
10 auth.
L. J. Veer,
M. V. Vijver,
H. Dai,
Yudong He,
A. Hart,
M. Mao,
...
C. J. Roberts,
R. Bernards,
P. Linsley,
S. Friend
|
3 |
2001 |
3
🐜
|
|
🐜
|
Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility
10 auth.
Bin Li,
S. Eschrich,
A. Berglund,
Melissa Mitchell,
D. Fenstermacher,
H. Danaee,
...
H. Dai,
Daniel M Sullivan,
W. Trepicchio,
W. Dalton
|
3 |
2017 |
3
🐜
|
|
🐜
|
Reinforcement Learning to Optimize the Treatment of Multiple Myeloma
16 auth.
K. Shain,
D. Hart,
A. Silva,
R. Alugubelli,
G. D. Avila,
P. Sudalagunta,
Alexandre Tungesvik,
Amit Kulkarni,
Carmelo Blancuicett,
H. Dai,
...
T. Nishihori,
J. Brayer,
Brandon Blue,
M. Alsina,
R. Baz,
W. Dalton
|
2 |
2019 |
2
🐜
|
|
🐜
|
Abstract 4725: Multiple Myeloma DREAM Challenge: A crowd-sourced challenge to improve identification of high-risk patients
24 auth.
M. Mason,
M. Amatangelo,
D. Auclair,
D. Bassett,
H. Dai,
A. Dervan,
E. Flynt,
H. Goldschmidt,
D. Hose,
K. Mavrommatis,
...
G. Morgan,
N. Munshi,
A. Ratushny,
Daniel K. Rozelle,
M. Samur,
F. Schmitz,
K. Shain,
A. Thakurta,
F. Towfic,
M. Trotter,
B. Walker,
B. S. White,
Thomas Yu,
J. Guinney
|
1 |
2017 |
1
🐜
|
|
🐜
|
Ex Vivo Drug Sensitivity and Functional Genomics Platform Identifies Novel Combinations Targeting Intrinsic and Extrinsic Apoptotic Signaling Pathways in Multiple Myeloma
19 auth.
A. Silva,
Rafael Renatino-Canevarolo,
M. Meads,
Maria C. Silva,
P. Sudalagunta,
C. Cubitt,
G. D. Avila,
R. Alugubelli,
Amit Kulkarni,
Melissa Mitchell,
...
H. Dai,
Qi Zhang,
O. Hampton,
Xin Lu,
D. Modi,
M. Motwani,
Jason G. Harb,
J. Ross,
K. Shain
|
1 |
2020 |
1
🐜
|
|
🐜
|
Systems Biology Analysis Identifies Targetable Vulnerability Networks to Proteasome Inhibitors in Multiple Myeloma
14 auth.
M. Meads,
Rafael R. Canevarolo,
P. Sudalagunta,
Paula S Oliveira,
D. Magaletti,
B. Fang,
Maria C. Silva,
Amit Kulkarni,
H. Dai,
W. Dalton,
...
I. Petre,
J. Koomen,
A. Silva,
K. Shain
|
0 |
2018 |
0
🐜
|
